$INGN News
Last published 5d ago
- 5d agoINGNTrading halt: Inogen, Inc (INGN), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-06 09:32:12.023 ET, resumption quote 2026-11-06 09:32:12 ET, resumption trade none.
- 6d agoINGNInogen 2026 Third Quarter Financial Results - INOGEN INCEarnings Call TranscriptsWelcome to Inogen's third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ask a question at that ti
- 6d agoINGNInogen Inc - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.01 Item 2.02 Item 5.02 Item 7.01 Item 8.01 Item 9.01
- 3w agoINGNInogen to Report Third Quarter 2026 Financial Results on November 5, 2026Business WireInogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2026 financial results after the
- 1mo agoINGNInogen Announces Divestiture of Its U.S. Oxygen Rental Business to RotechBusiness WireTransaction advances Inogen’s strategic shift toward a more streamlined commercial model supporting higher revenue growth and adjusted operating incomeInogen, Inc. (Nasdaq: INGN), a medical technology company offering
- 3mo agoINGNInogen Announces Second Quarter 2026 Financial ResultsBusiness WireReported second quarter revenue of $95.1 million Company raises full-year adjusted EBITDA guidance to approximately $4.0 million Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative
- 3mo agoBIRDINGNMKSILMNR+1Smartbird Nominates Tech Industry Veterans Elizabeth Mora and Dan Kasun for Election to Its Board of DirectorsGlobeNewswireSAN FRANCISCO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Smartbird, Inc. (NASDAQ:BIRD), an AI infrastructure provider, today announced the nomination of Elizabeth Mora and Dan Kasun for election to its board of directors at
- 3mo agoINGNInogen to Report Second Quarter 2026 Financial Results on August 6, 2026Business WireInogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2026 financial results after the
- 4mo agoINGNInogen Announces the Appointment of Andy Reding as Chief Operating OfficerBusiness WireNewly created role strengthens leadership structure to support Inogen’s global commercial and operational execution Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products
- 6mo agoINGNInogen 2026 First Quarter Financial ResultsINOGEN INCEarnings Call TranscriptsWelcome to Inogen's first quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ask a question at that ti
- 6mo agoINGNInogen Announces First Quarter 2026 Financial ResultsBusiness WireReported first quarter year-over-year revenue growth of 3.4% Company reiterates full-year 2026 guidance
- 6mo agoINGNInogen to Report First Quarter 2026 Financial Results on May 7, 2026Business Wire
- 7mo agoINGNInogen Announces the Appointment of Vafa Jamali to Board of DirectorsBusiness Wire
- 7mo agoINGNInogen Announces Participation in the 25th Annual Needham Virtual Healthcare ConferenceBusiness Wire
- 7mo agoINGNInogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- 7mo agoINGNInogen Announces Leadership Appointments Designed to Accelerate Next Phase of GrowthBusiness WireJason Richardson Named Chief Financial Officer, Succeeding Michael Bourque Dominic Hulton Named Chief Marketing Officer
- 8mo agoINGNInogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor ForumBusiness Wire
- 8mo agoINGNInogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial OutlookBusiness WireDelivered full year revenue growth of approximately 4% Significantly improved profitability with 2025 net loss of $22.7 million and positive adjusted EBITDA of $2.7 million
- 8mo agoINGNInogen Announces $30 Million Share Repurchase ProgramBusiness Wire
- 10mo agoINGNInogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United StatesBusiness WireExpansion Aligns with Innovation and Growth Strategy
- 1y agoINGNInogen Announces Third Quarter 2025 Financial ResultsBusiness WireDelivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance
- 1y agoINGNInogen to Report Third Quarter 2025 Financial Results on November 5, 2025Business WireInogen, Inc. (Nasdaq:
- 1y agoINGNInogen Announces the Appointment of Naga Rameswamy as Chief Technology OfficerBusiness Wire
- 1y agoINGNInogen, Inc. (INGN) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoINGNInogen Announces Second Quarter 2025 Financial ResultsBusiness WireDelivered strong top-line results; raising full year 2025 revenue expectations
- 1y agoINGNInogen to Report Second Quarter 2025 Financial Results on August 7, 2025Business WireInogen, Inc. (Nasdaq:
- 1y agoINGNInogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen TherapyBusiness Wire
- 1y agoINGNInogen Announces First Quarter 2025 Financial ResultsBusiness Wire
- 1y agoINGNInogen to Report First Quarter 2025 Financial Results on May 7, 2025Business WireInogen, Inc. (Nasdaq:
- 1y agoINGNInogen To Present at 24th Annual Needham Virtual Healthcare ConferenceBusiness Wire
- 1y agoINGNInogen Announces Fourth Quarter and Full Year 2024 Financial ResultsBusiness WireResults Reflect Strong Fourth Quarter 2024 Revenue Growth of 5.5%; Full-Year Revenue Growth of 6.4% Company Provides 2025 Growth Outlook Recently Announced Strategic Collaboration with Yuwell to Expa
- 1y agoINGNMDTMYOInogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom WestBusiness Wire
- 1y agoINGNInogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With YuwellBusiness Wire
- 1y agoINGNInogen Announces Preliminary Fourth Quarter and Full Year 2024 RevenueBusiness Wire
- 1y agoINGNInogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance DeviceBusiness Wire
- 2y agoINGNInogen, Inc. (INGN) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoINGNSGHTSight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, OperationsGlobeNewswireMENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
- 2y agoINGNInogen to Present at Upcoming Investor ConferencesBusiness Wire
- 2y agoINGNInogen to Report Third Quarter 2024 Financial Results on November 7, 2024Business WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POCBusiness WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen Appoints Eric Pauls as Vice President of Sales, North AmericaBusiness Wire
- 2y agoINGNInogen, Inc. (INGN) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoINGNInogen Announces Second Quarter 2024 Financial ResultsBusiness WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen to Report Second Quarter 2024 Financial Results on August 6, 2024Business WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business DevelopmentBusiness WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness RatioBusiness WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen, Inc. (INGN) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoINGNInogen Announces First Quarter 2024 Financial ResultsBusiness WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen to Report First Quarter 2024 Financial Results on May 7, 2024Business WireInogen, Inc. (Nasdaq:
- 2y agoINGNInogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceBusiness WireInogen, Inc. (Nasdaq: